BioCentury
ARTICLE | Company News

Daiichi Sankyo, Ranbaxy sales and marketing update

April 23, 2012 7:00 AM UTC

Ranbaxy's Terapia Ranbaxy Romanian subsidiary launched Sevikar in Romania to manage hypertension. Sevikar is a fixed-dose combination of olmesartan, an angiotensin II receptor blocker, amlodipine, a ...